Finasteride NDC 55111-171

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-171Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0171Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-171-05	55111017105	500 TABLET, FILM COATED in 1 BOTTLE (55111-171-05)Marketed from Jan 2, 2013
55111-171-18	55111017118	180 TABLET, FILM COATED in 1 BOTTLE (55111-171-18)Marketed from Jan 2, 2013
55111-171-30	55111017130	30 TABLET, FILM COATED in 1 BOTTLE (55111-171-30)Marketed from Jan 2, 2013
55111-171-90	55111017190	90 TABLET, FILM COATED in 1 BOTTLE (55111-171-90)Marketed from Jan 2, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Finasteride
Generic name (nonproprietary): finasteride
Active ingredients: Finasteride — 1 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Dr. Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076436
Marketing start: Jan 2, 2013
Listing expires: Dec 31, 2026
Other FDA classes: 5-alpha Reductase Inhibitors (Mechanism)
Identifiers: Product ID 55111-171_f7dbde3b-f358-c073-8516-fc07fa33303aSPL ID f7dbde3b-f358-c073-8516-fc07fa33303aSPL set ID fa19372d-027d-a91b-f58e-1bdb8fd7e2b6RxCUI 200172UNII 57GNO57U7G
Pharmacologic class: 5-alpha Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111017105 followed by a unit qualifier and the quantity

Package 55111-0171-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 19, 2024.

Indications (excerpt from the label)

Finasteride tablets are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY . Efficacy in bitemporal recession has not been established. Finasteride tablets are not indicated for use in women. Finasteride tablet is a 5α-reductase inhibitor indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY (1) . Finasteride tablets are not indicated for use in women ( 1 , 4 , 5.1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)